Newsletter | August 15, 2025

08.15.25 -- Epic Bio's Big Swing In Epigenetic Editing

SPONSOR

CRAACO: Clinical Research as a Care Option will be held September 15, 2025, in Philadelphia. This one-day event brings together stakeholders from across the life sciences and healthcare ecosystem to align clinical research with patient care. Learn how leading organizations are improving trial access, accelerating enrollment, and advancing integration. Use code LSL20 for 20% off your registration.

FROM THE EDITOR

Epic Bio's Big Swing In Epigenetic Editing

Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about epigenetic editing, working with the FDA, using AI for clinical endpoints, and more.

INDUSTRY INSIGHTS

Accelerating Gene Therapy Development For NEDAMSS

Discover how one family's race against time led to the creation of a groundbreaking gene therapy for their daughter, just 14 months after her ultra-rare disease diagnosis.

Sickle Cell Cure Within Reach, But At A Steep Cost

Treatment options for sickle cell disease (SCD) and newly available gene therapies represent a potential cure. However, the latter are costly and thus remain out of reach for many SCD patients.

Advancing Drug Safety: The Synergy Of Regulatory Affairs And Pharmacovigilance

Explore how pharmacovigilance and regulatory affairs teams work together throughout a product's lifecycle to monitor risks and keep vital safety information updated.

BsAb Development With Structural Innovation, Enhanced Manufacturability

Bispecific antibodies (bsAbs) offer transformative therapeutic potential through dual-target engagement, but their complex structure presents significant manufacturing challenges.

Transforming Oncology Trials With Next-Gen eCOA

With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.